Akari Therapeutics Plc (AKTX)

CIK 1541157 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Akari Therapeutics Plc.

Recent SEC filings

FiledFormAccession number
Aug 19, 202640001493152-26-039246
Aug 13, 20268-K0001493152-26-037736
Aug 13, 202610-Q0001493152-26-037730
Aug 12, 2026SCHEDULE 13G0000927971-26-000091
Aug 7, 2026SCHEDULE 13G0001952614-26-000004
Aug 5, 202640001493152-26-036231
Jul 17, 202640001493152-26-033634
Jul 13, 2026EFFECT9999999995-26-002279
Jul 10, 2026S-3/A0001493152-26-032841
Jul 8, 2026S-3/A0001493152-26-032503
Jul 7, 2026EFFECT9999999995-26-002205
Jul 2, 2026S-30001493152-26-031967
Jul 2, 20268-K0001493152-26-031972
Jun 26, 2026S-1/A0001493152-26-030330
Jun 26, 20268-K0001493152-26-030341
Jun 25, 202640001493152-26-030210
Jun 25, 202640001493152-26-030207
Jun 8, 2026SCHEDULE 13G0000912282-26-000802
Jun 4, 2026DEF 14A0001493152-26-027279
Jun 3, 2026D0001493152-26-027117
May 22, 2026PRE 14A0001493152-26-025051
May 22, 20268-K0001493152-26-025037
May 21, 2026RW0001493152-26-024741
May 19, 202610-Q0001493152-26-024446
May 18, 2026NT 10-Q0001493152-26-024230